Advertisement RemedyMD unveils ComprehensiveBMT for hematopoietic stem cell transplant research - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

RemedyMD unveils ComprehensiveBMT for hematopoietic stem cell transplant research

RemedyMD, a US based provider of registry software which helps scientists and researchers to aggregate, harmonize and identify patterns of data from widely disparate sources, has unveiled its new product - ComprehensiveBMT.

RemedyMD said ComprehensiveBMT solves key challenges of hematopoietic stem cell transplant (HSCT) research such as reporting data obtained from patients and donors (various disparate sources) after aggregating, linking, harmonizing, analyzing and reporting it as necessary to the CIBMTR.

ComprehensiveBMT product manager Matthew Gress said the company worked closely with the CIBMTR when building the forms included with the product, and users will now get the benefit of submitting forms electronically.

RemedyMD president and COO Jim Hyde said they are committed to using their technology platform to stay ahead of the new comprehensive forms as they are released.

Sample organizations using RemedyMD registries include Wisconsin’s Blood Research Institute, Children’s National Medical Center, Oklahoma Medical Research Foundation (OMRF), and several others.